Marlowe Jennifer's most recent trade in Solid Biosciences Inc was a trade of 90,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc | Marlowe Jennifer | CSO | 13 Feb 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | ||
Solid Biosciences Inc | Marlowe Jennifer | CSO | 13 Feb 2024 | 45,000 | 45,000 | - | - | Restricted Stock Units | ||
Solid Biosciences Inc | Jennifer Marlowe | CSO | 02 Dec 2023 | 11,888 | 35,667 | - | - | Restricted Stock Units | ||
Solid Biosciences Inc | Marlowe Jennifer | CSO | 02 Dec 2023 | 11,888 | 11,888 (0%) | 0% | - | Common Stock | ||
Solid Biosciences Inc | Jennifer Marlowe | CSO | 02 Dec 2023 | 4,890 | 6,998 (0%) | 0% | 2.8 | 13,525 | Common Stock | |
Solid Biosciences Inc | Jennifer Marlowe | CSO, FA & Cardiac | 02 Dec 2022 | 95,110 | 95,110 | - | - | Stock Option (Right to Buy) | ||
Solid Biosciences Inc | Jennifer Marlowe | CSO, FA & Cardiac | 02 Dec 2022 | 47,555 | 47,555 | - | - | Restricted Stock Units |